ArticleEfficacy and Safety of Ombitasvir, Paritaprevir and Ritonavir plus Ribavirin in Hepatitis C Genotype-4 Patients on Hemodialysis
ArticleEfficacy and Safety of Ombitasvir, Paritaprevir and Ritonavir plus Ribavirin in Hepatitis C Genotype-4 Patients on Hemodialysis
ArticleThe Efficacy and Safety of Treatment of Chronic HCV Infection by Ombitasvir/Paritaprevir/Ritonavir with Ribavirin and its Effect on Complement C3 and C4 Levels
ArticleThe Efficacy and Safety of Treatment of Chronic HCV Infection by Ombitasvir/Paritaprevir/Ritonavir with Ribavirin and its Effect on Complement C3 and C4 Levels
ArticleEfficacy and Safety in Difference Combination of Sofosbuvir in Treatment of Chronic Hepatitis C Virus
ArticleEfficacy and Safety in Difference Combination of Sofosbuvir in Treatment of Chronic Hepatitis C Virus
ArticleEfficacy of Ombitasvir/Paritaprevir/Ritonavir plus Ribavirin in Treatment of Chronic Hepatitis C Patients with End Stage Renal Disease on Regular Hemodialysis
ArticleEfficacy of Ombitasvir/Paritaprevir/Ritonavir plus Ribavirin in Treatment of Chronic Hepatitis C Patients with End Stage Renal Disease on Regular Hemodialysis
ArticleSafety and Efficacy of Ombitasvir, Paritaprevirand Ritonavir Combination with Ribavirin for Treatment of Chronic Hepatitis C Virus in Advanced Kidney Diseases Patients in Upper E
ArticleSafety and Efficacy of Ombitasvir, Paritaprevirand Ritonavir Combination with Ribavirin for Treatment of Chronic Hepatitis C Virus in Advanced Kidney Diseases Patients in Upper E
ArticleComparing The Efficacy and Safety of (Ombitasvir/ Paritaprevir/ Ritonavir) in Management of Chronic HCV Patients Among Haemodialysis Patients and Those with Normal Renal Functions
ArticleComparing The Efficacy and Safety of (Ombitasvir/ Paritaprevir/ Ritonavir) in Management of Chronic HCV Patients Among Haemodialysis Patients and Those with Normal Renal Functions
ArticleEvaluation of efficacy and safety of daclatasvir and sofosbuvir in treatment of chronic hepatitis C infection
ArticleEvaluation of efficacy and safety of daclatasvir and sofosbuvir in treatment of chronic hepatitis C infection
ArticleEfficacy and Adverse Effects of Sofosbuvir-Based Therapies (Double and Triple Regimens) in Chronic HCV Patients
ArticleEfficacy and Adverse Effects of Sofosbuvir-Based Therapies (Double and Triple Regimens) in Chronic HCV Patients
ArticleEfficacy and Safety of Daclatasvir and Sofosbuvir in Egyptian Patients with Chronic Hepatitis C Genotype 4 and Cirrhosis
ArticleEfficacy and Safety of Daclatasvir and Sofosbuvir in Egyptian Patients with Chronic Hepatitis C Genotype 4 and Cirrhosis